D-0314-2021 Class III Terminated
FDA drug recall D-0314-2021 was initiated by Cardinal Health Inc. on Mar 9, 2021 and is designated Class III. Reason for recall: Temperature Abuse The recall status is terminated (terminated Nov 4, 2021). Affected quantity: 48 boxes.
Recall details
- Product Type
- Drugs
- Report Date
- Apr 7, 2021
- Initiation Date
- Mar 9, 2021
- Termination Date
- Nov 4, 2021
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 48 boxes
Product description
Tremfya (guselkumab) Injection, 100 mg/mL, one single-dose prefilled syringe per carton, Rx only, Manufactured by: Janssen Biotech, Inc., Horsham, PA 19044; NDC 57894-640-01.
Reason for recall
Temperature Abuse
Distribution pattern
AL, LA, MS, TN
Code information
KESOY.AI Exp. 04/2022
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0314-2021
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026